BASi® provides drug developers with superior scientific research and innovative analytical instrumentation, which saves time, saves money, and saves lives, to bring revolutionary new drugs to market quickly and safely.
Founded in 1974, Bioanalytical Systems, Inc. (BASi) is a publicly traded, global company headquartered in West Lafayette, Indiana, that provides contract research services and sophisticated, niche instrumentation to the life sciences industry, primarily in drug research, discovery, and development in commercial and academic settings. BASi also provides critical testing services for biotech and the rapidly growing generic and biosimilars drug sectors.
For four decades, BASi has established itself as an industry leader in contract research and as a resource for instrumentation that meets the demanding requirements of today’s research labs. This can be attributed to an exceptional scientific team, originally established by company founder, Purdue University chemistry professor Peter Kissinger, and our leadership team, all of whom are results oriented and client focused. Indeed, the world’s leading pharmaceutical companies, academic centers, and myriad of startup companies in drug development and biotech count on BASi’s expertise in the demanding fields like electrochemistry and mass spectrometry; our unique capabilities in liquids, creams, patches and transdermals; and our unparalleled record with FDA audits to execute projects accurately, on schedule and on budget.
BASi instrumentation like the BASi Culex NxT™ automated sampling system can be found in labs around the world and is readily available through our dynamic online “store”. This dynamic portal provides customers with a wealth of information, access to experts, the ability to customize instrumentation for their lab, and a wide range of consumables. BASi has a second location near Evansville, Indiana, dedicated to meeting the requirements of the preclinical toxicology and veterinary markets via animal models.
Studies: Pilot/lead optimization, Acute, Sub-chronic, Chronic
Species: Rodents, Canines, Nonhuman Primates, Swine/Minipigs, Rabbits, Guinea pigs
Routes of Administration: Oral (Gavage, Capsule/tablet), Parenteral (Intramuscular, Intraperitoneal, Intravenous, Subcutaneous, Sublingual, Dermal, Intradermal, Ocular, Intravaginal, Rectal, Intranasal)
Our in vivo automated sampling lab is one of the largest in the USA. We have stationed 48 automated sampling Culex systems for a quick turn-around of your PKPD data. Our goal is to provide you with studies that meet your unique information needs while minimizing the number of study animals.
BASi® has proven experience and expertise with the FDA guidance documents and regulations on In Vitro Bioequivalence studies. The group's pharmaceutical product testing expertise mixed with the corporation's knowledge of bioequivalence studies and regulations creates the perfect match for our In Vitro services. BASi leverages the FDA guidances and all applicable literature sources to develop a sound scientific, regulatory plan.
BASi has not received any reviews.
BASi has not received any endorsements.